NEUROD1 and Stroke: Notably, there was a significant decrease in the relative fraction of XFP+GFAP-NeuN- cells at PSD63 in Neurod1-injected mice when compared to Cre controls (stroke/Cre_63d, 19.0 ± 2.7 vs. stroke/Neurod1_63d, 11.1 ± 1.5; p = 0.022).